Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tsunoda K., Abe K., Hagino T., Omata K., Misawa S., Imai Y., and Yoshinaga K., 1993, Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension. Am J Hypertens 6: 28–32
Burnier M., Roch-Ramel F., and Brunner H.R., 1996, Renal effects of angiotensin II receptor blockade in normotensive subjects. Kidney Int 49: 1787–1790
Steele T.H., 1969, Evidence for altered renal urate reabsorption during changes in volume of extracellular fluid. J Lab Clin Med 74: 288–299.
Iwaki K., and Yonetani Y., 1984, Decreased renal excretion of uric acid following diuretic administration in rats. Jpn J Pharmacol 34: 389–396
Yamamoto T., Moriwaki Y., Takahashi S., Tsutsumi Z., Hiroishi K., Yamakita J., Nakano T., and Higashino K., 1997, Effect of glucagon on renal excretion of oxypurinol and purine bases. J Rheumatol 24: 708–713
Yamamoto T., Moriwaki Y., Takahashi S., Suda M., and Higashino K., 1996, The effect of amino acid infusion on purine bases and oxypurinol. Nephron 73, 41–47
Yamamoto T., Moriwaki Y. Takahashi S., Suda M., and Higashino K., Effect of pyrazinamide, probenecid and benzbromarone on renal 1991, excretion of oxypurinol. Ann Rheum Dis 50, 631–633.
Appelbaum S.J., Mayersohn M., Dorr T.R., and Perrier D., 1982, Allopurinol kinetics and bioavailability: Intravenous, oral and rectal administration. Cancer Chemother Pharmacol 8: 93–98
Hande K., Reed E., and Chabner B., 1972, Allopurinol kinetics. Clin Pharmacol Ther 23: 598–605
Elion G.B., Kovensky A., Hitchings G.H., Metz E., and Rundles R. W., 1966, Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol 15: 963–980
Roth-Ramel F., Guisan B., and Diezi J., 1997, Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles. J Pharmacol Exp Ther 280: 839–845
Löffler W., Grobner W., und Zollner N., 1983; Harnsauresenkende wirkung einer kombination von benzbromaron und allopurinol-untresuchungen unter standardiserten ernahrungsbedingungen. Arzneimittelforschung 33: 1687–1691
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Yamamoto, T., Moriwaki, Y., Takahashi, S., Tsutsumi, Z., Hada, T. (2002). Effect of Losartan and Furosemide on the Urinary Excretion of Oxypurinol and Uric Acid. In: Zoref-Shani, E., Sperling, O. (eds) Purine and Pyrimidine Metabolism in Man X. Advances in Experimental Medicine and Biology, vol 486. Springer, Boston, MA. https://doi.org/10.1007/0-306-46843-3_38
Download citation
DOI: https://doi.org/10.1007/0-306-46843-3_38
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46515-4
Online ISBN: 978-0-306-46843-8
eBook Packages: Springer Book Archive